Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling

International Journal of Cancer

Volumn 119, Issue 4, 2006, Pages 823-830

  Horiuchi, Sankichi ^a   Yamamoto, Norio ^a   Dewan, Md Zahidunnabi ^a,b   Takahashi, Yoshiaki ^c   Yamashita, Atsuya ^d   Yoshida, Tsutomu ^e   Nowell, Mari A ^f   Richards, Peter J ^f   Jones, Simon A ^f   Yamamoto, Naoki ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e Biophenix Co Ltd   (Japan)

^f CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

HTLV I; IL 6R; STAT3

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 6 RECEPTOR; RNA; STAT3 PROTEIN; TAX PROTEIN;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA; LEUKEMIA CELL LINE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOCYTE;

CELL LINE; CELL PROLIFERATION; CULTURE MEDIA; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-6; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; SOLUBILITY; STAT3 TRANSCRIPTION FACTOR;

EID: 33745899609     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21918     Document Type: Article

References (56)

1. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981;78:6476-80.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9.
3. Gessain A, Barin F, Vemant JC, Gout O, Maurs L, Calender A, The GD. Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
4. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989;1:441.
5. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992;83:236-9.
6. Green PL, Chen ISY. Human T-cell leukemia virus type 1 and 2. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia: Lippincott Williams and Wilkines, 2001. 1941-61.
7. Yamamoto N, Matsumoto T, Koyanagi Y, Tanaka Y, Hinuma Y. Unique cell lines harbouring both Epstein-Barr virus and adult T-cell leukaemia virus, established from leukaemia patients. Nature 1982;299:367-9.
8. Akagi T, Ono H, Shimotohno K. Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. Blood 1995;86:4243-9.
9. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, Nishioka K, Yamamoto K, Takeda T, Hatanaka M, Yamamoto H, Sekiguchi T. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 1991;253:1026-8.
10. Ballard DW, Bohnlein E, Lowenthal JW, Wano Y, Franza BR, Green WC. HTLV-I tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 1988;241:1652-5.
11. Fujii M, Niki T, Mori T, Matsuda T, Matsui M, Nomura N, Seiki M. HTLV-I Tax induces expression of various immediate early serum responsive genes. Oncogene 1991;6:1023-9.
12. Huang Y, Ohtani K, Iwanaga R, Matsumura Y, Nakamura M. Direct trans-activation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I. Oncogene 2001;20:1094-102.
13. Mori N, Prager D. Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 1996;87:3410-7.
14. Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M. Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002;100:1828-34.
15. Kishimoto T, Hirano T. Molecular regulation of B lymphocyte response. Annu Rev Immunol 1988;6:485-512.
16. Gauldie J, Richards C, Hamish D, Lansdorp P, Baumann H. Interferon β 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987;84:7251-5.
17. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987;84:9035-9.
18. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science 1988;241:825-8.
19. Taga T, Kawanishi Y, Hardy RR, Hirano T, Kishimoto T. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J Exp Med 1987;166:967-81.
20. Hurst S, Wilkinson T, Mcloughlin R, Jones SA, Horiuchi S, Yamamoto N, Rose-Jone S, Fuller G, Topley N, Jones S. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001;14:705-14.
21. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 2001;15:43-58.
22. Desgeorges A, Gabay C, Silacci P, Novick D, Roux-Lombard P, Grau G, Dayer JM, Vischer T, Gueme PA. Concentrations and origins of soluble interleukin 6 recepter-α in serum and synovial fluid. J Rheumatol 1997;24:1510-6.
23. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T, Osugi Y, Tokunaga T, Kishimoto T. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 1992;148:2175-80.
24. Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human disease. Biochim Biophys Acta 2002;1592:323-43.
25. Jones SA, Rose-John S. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6. R/IL-6 complex. Biochim Biophys Acta 2002;1592:251-63.
26. Horiuchi S, Ampofo W, Koyanagi Y, Yamashita A, Waki M, Matsumoto A, Yamamoto M, Yamamoto N. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy. Immunology 1998;95:360-9.
27. Yoshida T, Miyagawa E, Yamaguchi K, Kobayashi S, Takahashi Y, Yamashita A, Miura H, Itoyama Y, Yamamoto N. IL-2 independent transformation of unique human T cell line, TY-8-3 and its subclones by HTLV-I and -II. Int J Cancer 2001;91:99-108.
28. Kannagi M, Kuroda M, Maeda Y, Harada S. Coexistence of fusion receptors for human T-cell leukemia virus type-1 (HTLV-I) and human immunodeficiency virus type-I (HIV-I) on MOLT-4 cells. Microbiol Immunol 1991;35:729-40.
29. Ohtani K, Nakamura M, Saito S, Nagata K, Sugamura K, Hinuma Y. Electroporation: application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type 1. Nucl Acids Res 1989;17:1589-604.
30. Ohtani K, Tsujimoto A, Tsukahara T, Numata N, Miura S, Sugamura K, Nakamura N. Molecular mechanisms of promorter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I. J Biol Chem 1998;273:14119-29.
31. Horiuchi S, Koyanagi Y, Zhou Y, Miyamoto H, Tanaka Y, Waki M, Matsumoto A, Yamamoto M, Yamamoto N. Soluble interleukin-6 receptor released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol 1994;24:1945-8.
32. Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Le Bail O, Urban MB, Kourilsky P, Beauerle PA, Israel A. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 1990;62:1007-18.
33. Yoshida M. HTLV-I oncoprotein Tax deregulates transcription of cellular genes through multiple mechanisms. J Cancer Res Clin Oncol 1995;121:521-8.
34. McGuire KL, Curtiss VE, Larson EL, Haseline WA. Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression. J Virol 1993;67:1590-9.
35. Mariner JM, Lantz V, Waldmann TA, Azimi N. Human T cell lymphotropic virus type I Tax activates IL-15. R alpha gene expression through an NF-κB site. J Immunol 2001;166:2602-9.
36. Mon N, Shirakawa F, Shimizu H, Murakami S, Oda S, Yamamoto K, Eto S. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type 1-infected T-cell lines: evidence for the involvement of NF-κB. Blood 1994;84:2904-11.
37. 2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells. Eur J Immunol 1998;28:3514-22.
38. Jones SA, Novick D, Horiuchi S, Topley N, Yamamoto N, Szalai AJ, Fuller GM. C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J Exp Med 1999;189:599-604.
39. Nowell MA, Richards PJ, Horiuchi S, Yamamoto N, Rose-John S, Topley N, Williams AS, Jones AS. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol 2003;171:3202-9.
40. Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M, Yamaguchi K, Takatsuki K, Kamihira S, White JD, Leonard WJ, Waldmann T, et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA 1997;94:13897-902.
41. Darnell JE, Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-21.
42. Uchiyama T. Human T cell leukemia virus type 1 (HTLV-I) and human diseases. Annu Rev Immunol 1997;15:15-37.
43. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CRM, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998;4:586-93.
44. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000;19:2474-88.
45. Migone TS, Lin JX, Cereseto A, Mulloy JC, Oshea JJ, Franchini G, Leonard WJ. Constitutively activated Jak-Stat pathway in T cells transformed with HTLV-I. Science 1995;269:79-81.
46. Nakamura N, Fujii M, Tsukahara T, Arai M, Ohashi T, Wakao H, Kannagi M, Yamamoto N. Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells. Oncogene 1999;18:2667-75.
47. Zhang Q, Lee B, Korecka M, Li G, Weyland C, Eck S, Gessain A, Arima N, Lessin SR, Shaw LM, Luger S, Kamoun M, et al. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I (+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia. Leuk Res 1999;23:373-84.
48. Umehara F, Izumo S, Takeya M, Takahashi K, Sato E, Osame MM. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta neuropathol (Berl) 1996;91:343-50.
49. Arai M, Ohashi T, Tsukahara T, Murakami T, Hori T, Uchiyama T, Yamamoto N, Kannagi M, Fujii M. Human T-cell leukemia virus type 1 tax protein induces the expression of lymphocyte chemoattractant SDF-1/PBSF. Virology 1998;241:298-303.
50. Mihara M, Moriya Y, Kishimoto T, Ohsugi Y. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 1995;34:321-5.
51. Modur V, Li Y, Zimmerman GA, Prescott SM, Mcintyre TM. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest 1997;100:2752-6.
52. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, Van Hinsbergh V, Sozzani S, Bussolino F, Poli V, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997;6:315-25.
53. McLoughlin RM, Witowski J, Robson RL, Wilkinson TS, Hurst SM, Williams AS, Williams JD, Rose-John S, Jones SA, Topley N. Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 2003;112:598-607.
54. Teague TK, Marrack P, Kappler JW, Vella AT. IL-6 rescues resting mouse T cells from apoptosis. J Immunol 1997;158:5791-6.
55. Atreya R, Mudter J, Finotto S, Mullberg J, Jostocjk T, Wirwtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 2000;6:583-8.
56. Teague TK, Schaefer BC, Hildeman D, Bender J, Mitchell T, Kappler JW, Marrack P. Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signalling. J Exp Med 2000;191:915-25.